Top Markets
Coin of the day
Aziyo Biologics, Inc. Aziyo Biologics, Inc.

Aziyo Biologics, Inc.

AZYO
शेयरों में रैंक #29676
Aziyo Biologics, Inc. (AZYO) operates as a regenerative medicine firm,... Aziyo Biologics, Inc. (AZYO) operates as a regenerative medicine firm, concentrating its efforts on developing advanced medical products. Their primary applications target three key areas: implantable electronic devices and cardiovascular care, orthopedic and spinal repair, and the reconstruction of soft tissues. The company's product portfolio includes CanGaroo, an innovative envelope that incorporates antibiotics, specifically engineered to lower the risk of infection following the surgical implantation of an electronic device. Aziyo also provides a suite of cardiovascular solutions. ProxiCor serves as an intracardiac patch or pledget for repairing heart tissues, while Tyke is designed for neonates and infants to mend pericardial structures. Additionally, VasCure offers a versatile patching material for the repair or reconstruction of peripheral blood vessels, encompassing critical arteries like the carotid, renal, iliac, femoral, and tibial, serving cardiovascular, vascular, and general surgeons. For orthopedic procedures, Aziyo offers human tissue-derived bone allografts such as Fiber VBM, ViBone, and OsteGro V. These products are formulated to protect and preserve the body's natural bone cells. In the realm of soft tissue repair, they feature SimpliDerm, a pre-hydrated human acellular dermal matrix (HADM) developed for the repair or replacement of damaged or insufficient skin and related integumental tissues. Beyond its proprietary product line, Aziyo Biologics extends contract manufacturing services, producing various items for other corporate clients. The company distributes its products to hospitals and other healthcare facilities through a multi-faceted sales approach, utilizing its dedicated direct sales force, strategic commercial partners, and independent sales agents. Founded in 2015, Aziyo Biologics, Inc. maintains its headquarters in Silver Spring, Maryland.
शेयर मूल्य
$1.39
अंतिम समन्वयन: 2023-10-03
मार्केट कैप
$20.11M
बदलाव (1 दिन)
-3.47%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Aziyo Biologics, Inc. (AZYO)

श्रेणी

Aziyo Biologics, Inc. (AZYO) के लिए EPS
2026 TTM तक का EPS: 0
Aziyo Biologics, Inc. की नवीनतम वित्तीय रिपोर्टों और शेयर मूल्य के अनुसार, कंपनी का वर्तमान EPS (TTM) 0 है। 2026 के अंत में, कंपनी का EPS 0 था, जो 2026 के EPS 0 के के बराबर था।
Aziyo Biologics, Inc. के लिए 2026 से 2026 तक का EPS इतिहास
प्रत्येक वर्ष के अंत में EPS
वर्ष EPS परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए EPS
कंपनी EPS EPS अंतर देश
$3.11 -
US
$9.73 -
US
$3.59 -
IE
$2.48 -
US
$1.74 -
US